Key Segmentation
By Modality
-
Optical Imaging/Bioluminescence & Fluorescence Imaging
-
PET/Positron Emission Tomography
-
SPECT
-
MRI
-
CT
-
Ultrasound
-
Photoacoustic Imaging
-
Multimodal/Hybrid Imaging Systems
By Application
-
Research & Development
-
Drug Discovery & Development
-
Toxicology Studies
-
Disease Mechanism Studies
-
Oncology Research
-
Neurology Research
-
Others
By End User
-
Pharmaceutical & Biotechnology Companies
-
Research Institutes & Academic Centres
-
Contract Research Organizations
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
The Preclinical Imaging Market was valued at USD 4.58 Billion in 2025.
Increased investments in research and development, advancements in imaging systems technology, and increasing demand for non-invasive techniques in drug discovery and disease research contributing to market growth.
Optical Imaging dominated the Preclinical Imaging Market with 11.9% share in 2025.
North America dominated the global preclinical imaging market in 2025 with 28.3% of global revenue.